You are hereAugust 18, 2009
Partnership for Stem Cells journal
For Immediate Release
Wiley-Blackwell and AlphaMed Press Announce New Co-Publishing
Partnership for Stem Cells journal
Hoboken, NJ, and Durham, NC, July 28, 2008— Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc. and AlphaMed Press today announced that Wiley-Blackwell has been selected to serve as co-publisher of Stem Cells.
Stem Cells, the international journal of cell differentiation and proliferation, is co-edited by Dr. Donald G. Phinney and Dr. Miodrag Stojković and a global editorial board. The Journal publishes peer-accepted original articles and concise reviews describing basic laboratory investigations of stem cells and the translation to patient care. It also provides a forum for young investigators to present provocative proposals for new research directions. The journal covers all aspects of stem cells and regenerative medicine including embryonic stem cells; induced pluripotent stem cells; tissue-specific stem cells; cancer stem cells; the stem cell niche; stem cell epigenetics, genomics and proteomics; translational and clinical research; and technology development. With an Impact Factor of 7.531 Stem Cells is in the top 3% of all high impact international journals.
“We are proud to have engaged Wiley-Blackwell as our co-publisher of Stem Cells effective January 1, 2009. For the past twenty-six years the journal Stem Cells has been the premier journal devoted exclusively to stem cell biology and its clinical applications,” reflected Ann Murphy, PhD., President of AlphaMed Press. By partnering with Wiley-Blackwell, a highly respected publisher with worldwide reach, the Journal’s impact will be enhanced and, in turn, it will foster research that offers such promise.”
Wiley-Blackwell serves as publisher for over 750 publishing partners, providing the scholarly community with access to the highest-quality content available. “Through AlphaMed Press’ visionary work, Stem Cells has made an enormous impact on development of the field of stem cell science and regenerative medicine,” said Colette E. Bean, Publisher. “In collaboration, we expect to make considerable advances in the content and delivery of information, which we hope will have a lasting and profound benefit to the stem cells scientific community.”
For more information about Stem Cells visit: www.StemCells.com
About AlphaMed Press
Established in 1983, AlphaMed Press with offices in Durham, NC and Craigavon, United Kingdom publishes two internationally renowned peer-reviewed journals: Stem Cells®, now in its 26th year, is the world’s first journal devoted to this fast paced field of research. The Oncologist® (www.TheOncologist.com), also a monthly peer-reviewed publication, is in its 13th year and is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. Both journals are premier periodicals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. AlphaMed Press publishes the Stem Cells Portal online (www.StemCellsPortal.com), as well as freestanding monographs and books, and is renowned for its excellence and speed in the publication of the peer-reviewed proceedings of major international symposia.
Wiley-Blackwell was formed in February 2007 as a result of the acquisition of Blackwell Publishing Ltd. by John Wiley & Sons, Inc., and its merger with Wiley's Scientific, Technical, and Medical business. Together, the companies have created a global publishing business with deep strength in every major academic and professional field. Wiley-Blackwell publishes approximately 1,400 scholarly peer-reviewed journals and an extensive collection of books with global appeal. For more information on Wiley-Blackwell, please visit www.blackwellpublishing.com or http://interscience.wiley.com .
Founded in 1807, John Wiley & Sons, Inc. has been a valued source of information and
understanding for 200 years, helping people around the world meet their needs and fulfill their aspirations. Since 1901, Wiley and its acquired companies have published the works of more than 350 Nobel laureates in all categories: Literature, Economics, Physiology/Medicine, Physics, Chemistry and Peace.
Our core businesses include scientific, technical, medical and scholarly journals, encyclopaedias, books, and online products and services; professional/trade publishes books, subscription products, training materials, and online applications and websites; and educational materials for undergraduate and graduate students and lifelong learners. Wiley's global headquarters are
located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's Web site can be accessed at http://www.wiley.com . The Company is listed on the New York Stock Exchange under the symbols JWa and JWb.